Ubrogepant 是新型的、口服有效的降钙素基因相关肽受体拮抗剂。Ubrogepant 有潜力用于急性偏头痛的相关研究。
产品描述
Ubrogepant is an antagonist of calcitonin gene-related peptide receptor that can be used in the acute treatment of migraine studies.
Cas No.
1374248-77-7
分子式
C29H26F3N5O3
分子量
549.54
别名
MK-1602
储存和溶解度
DMSO:245 mg/mL (445.83 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
m.cnreagent.com
